What is the prevalence of Cloacal exstrophy?

TL;DR: Cloacal exstrophy is an ultra-rare congenital anomaly with an estimated incidence of approximately 1 in 200,000 to 1 in 400,000 live births. Because it is a severe developmental condition identified at birth, it is classified as a pediatric-onset disorder, though advancements in surgical care mean that more individuals with cloacal exstrophy are now living into adulthood.

What is the estimated prevalence and incidence of cloacal exstrophy?

Cloacal exstrophy is considered an ultra-rare condition, meaning it affects a very small fraction of the global population. According to the National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD), the incidence is estimated to be between 1 in 200,000 and 1 in 400,000 live births. Because cloacal exstrophy is a major structural malformation that is clinically apparent immediately upon birth, the incidence rate is generally considered a reliable proxy for prevalence in pediatric populations. However, exact global prevalence is difficult to determine because survival rates have historically varied, and registry data is often incomplete.

Does cloacal exstrophy affect genders or populations differently?

Data regarding sex distribution in cloacal exstrophy indicates that it may affect both biological males and females, though some clinical literature suggests a slight male predominance in reported cases. There is no currently recognized geographic or ethnic predisposition for the condition. While the condition is rare, researchers note that cloacal exstrophy is not tied to a specific ancestry, occurring sporadically across all populations worldwide.

What challenges exist in gathering accurate data for this condition?

Accurate epidemiological data for cloacal exstrophy faces several hurdles. First, the severity of the condition can lead to pregnancy loss or neonatal mortality, which may result in under-reporting in standard birth registries. Second, because it is an "ultra-rare" disease, many medical centers may only see one or two cases in a decade, making large-scale data collection difficult. At DiseaseMaps.org, 5 people with cloacal exstrophy have joined our community, providing a vital, real-world perspective that complements clinical statistics by highlighting the long-term, lived experience of survivors that is often missing from traditional medical literature.

Key epidemiological facts about cloacal exstrophy

• Classification: Ultra-rare, congenital, and structural.


• Age of Onset: Always present at birth (congenital).


• Estimated Incidence: 1 in 200,000 to 400,000 live births (NIH GARD).


• Diagnostic Timing: Typically identified via prenatal ultrasound or immediate physical examination at birth.

Next steps

• Consult with a pediatric urologist or a pediatric surgeon specializing in colorectal reconstruction to discuss long-term care plans.


• Connect with the cloacal exstrophy community on DiseaseMaps.org to share experiences and find peer support.


• Review resources from the NIH GARD or the Exstrophy/Epispadias community foundations for specialized patient advocacy and clinical updates.


• Ensure that your medical history is recorded in a rare disease registry to help improve future research and epidemiological accuracy.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cloacal exstrophy overview.


• Orphanet: Rare disease database entry for cloacal exstrophy (ORPHA:326).


• OMIM (Online Mendelian Inheritance in Man): Entry regarding the genetics and clinical presentation of cloacal exstrophy.


• DiseaseMaps.org: Community patient data and real-world experiences.